Proficio Capital Partners LLC Purchases New Shares in Simulations Plus, Inc. (NASDAQ:SLP)

Proficio Capital Partners LLC acquired a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) during the fourth quarter, HoldingsChannel reports. The fund acquired 25,770 shares of the technology company’s stock, valued at approximately $719,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its position in Simulations Plus by 4.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 143,253 shares of the technology company’s stock worth $3,995,000 after purchasing an additional 6,418 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. US Bancorp DE grew its position in shares of Simulations Plus by 14.3% during the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after buying an additional 713 shares during the period. Illumine Investment Management LLC bought a new stake in shares of Simulations Plus during the fourth quarter worth approximately $280,000. Finally, Olympiad Research LP acquired a new position in Simulations Plus in the fourth quarter valued at approximately $211,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on SLP. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. KeyCorp upped their target price on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $49.40.

Insider Activity

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 19.40% of the stock is owned by corporate insiders.

Simulations Plus Stock Up 3.6 %

Shares of SLP stock opened at $25.56 on Friday. The company has a market capitalization of $513.55 million, a price-to-earnings ratio of 63.90 and a beta of 0.89. Simulations Plus, Inc. has a 12-month low of $24.00 and a 12-month high of $51.22. The firm has a fifty day moving average of $31.29 and a 200-day moving average of $30.88.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.